Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Armer

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|March 16, 2001
Recent advances in atypical antipsychoticsR Armer, D J Miller
Idrugs : the Investigational Drugs Journal|August 2, 2005
Recent advances in atypical antipsychoticsR Armer, D J Miller
RSC Medicinal Chemistry|June 7, 2021
Rational design, synthesis and testing of novel tricyclic topoisomerase inhibitors for the treatment of bacterial infections part 2R Kirk, A Ratcliffe, G Noonan, et al.
RSC Medicinal Chemistry|June 7, 2021
Rational design, synthesis and testing of novel tricyclic topoisomerase inhibitors for the treatment of bacterial infections part 1R Kirk, A Ratcliffe, G Noonan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Opinion in Investigational Drugs (London, England : 2000)|March 16, 2001
Recent advances in atypical antipsychoticsR Armer, D J Miller
Idrugs : the Investigational Drugs Journal|August 2, 2005
Recent advances in atypical antipsychoticsR Armer, D J Miller
RSC Medicinal Chemistry|June 7, 2021
Rational design, synthesis and testing of novel tricyclic topoisomerase inhibitors for the treatment of bacterial infections part 2R Kirk, A Ratcliffe, G Noonan, et al.
RSC Medicinal Chemistry|June 7, 2021
Rational design, synthesis and testing of novel tricyclic topoisomerase inhibitors for the treatment of bacterial infections part 1R Kirk, A Ratcliffe, G Noonan, et al.
Pageof 1